Newsroom

Displaying 1–10 of 142

August 3, 2026

Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference 

August 3, 2026

Seer to Report Second Quarter 2026 Financial Results on August 11, 2026

July 30, 2026

Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.

July 28, 2026

Seer Stockholders Vote to Re-Elect All Seven of Seer’s Director Nominees at 2026 Annual Meeting

July 20, 2026

Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY

July 20, 2026

Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.

July 14, 2026

Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight

July 8, 2026

Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees

July 6, 2026

Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential

July 2, 2026

Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.

Starting your proteomics research is effortless

Connect with an expert to discuss which path to the full proteome is right for you.

  1. Bring the Proteograph Product Suite in-house
  2. Run a project with
    Seer Technology
    Access Center
  3. Conduct a project with
    a Seer service provider
    or Center of Excellence